Paulo Nunes dos Santos / Bloomberg via Getty Images Eli Lilly will report third-quarter earnings Wednesday morning, with the focus remaining on the production and sales of its popular weight-loss ...
Last week, the Food and Drug Administration declared an end to the shortage of Eli Lilly’s tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for obesity. The move was a ...
A change in the dosing regimen of Eli Lilly’s Alzheimer’s drug Kisunla resulted in a lower rate of brain swelling among patients in a clinical trial, new data reported Tuesday show.
Thrusting out from the mezzanine level of London’s The Royal Exchange, two distinct dining concepts get ready to open their doors: Engel, an intimate cocktail bar inspired by 1920s Berlin; and Jang, a ...
Coming off a brutal 41-10 loss to Texas A&M, Missouri head coach Eli Drinkwitz was eager to see the way his team would respond. Here's all he had to say after the team's win to round out its non ...
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...
Eli Lilly has ben able to increase its manufacturing capacity to meet demand for its GLP-1 drugs. The company hopes this will reduce competition from drug compounding businesses. The stock looks ...
Nico Chen has given his Buy rating due to a combination of factors including Eli Lilly’s strong revenue growth and the potential expansion of its diabetes medication Mounjaro. Chen recognizes ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback